GUTS: Revita aims to transform post-GLP-1 weight maintenance with pivotal data and U.S. launch targeted for 2028
Revita is positioned as a durable, outpatient solution for post-GLP-1 weight maintenance, with pivotal data and a regulatory filing expected soon. The commercial strategy targets top bariatric centers, leveraging existing infrastructure and a favorable safety profile. CMS policy and early coverage…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.